{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Elliptinium_Acetate",
  "nciThesaurus": {
    "casRegistry": "58337-35-2",
    "chebiId": "",
    "chemicalFormula": "C18H17N2O.C2H3O2",
    "definition": "Acetate salt of elliptinium, a derivative of the alkaloid ellipticine isolated from species of the plant family Apocynaceae, including Bleekeria vitensis, a plant with anti-cancer properties.  As a topoisomerase II inhibitor and intercalating agent, elliptinium stabilizes the cleavable complex of topoisomerase II and induces DNA breakages, thereby inhibiting DNA replication and RNA and protein synthesis.",
    "fdaUniiCode": "H9B41234P4",
    "identifier": "C1367",
    "preferredName": "Elliptinium Acetate",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1968",
      "C582"
    ],
    "synonyms": [
      "6H-Pyrido[4, 3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-acetate (salt)",
      "9-Hydroxy-2,5,11-trimethyl-6H-pyrido[4,3-b]carbazolium Acetate (Salt)",
      "9-Hydroxy-2-methylellipticinium Acetate",
      "9-Hydroxy-2-methylellipticinium acetate",
      "Celiptium",
      "ELLIPTINIUM ACETATE",
      "Elliptinium Acetate",
      "N-2-Methyl-9-hydroxyellipticinium Acetate"
    ]
  }
}